Sky Medical Technology, a UK-based biomedical devices company announced that its geko™ device was presented as part of the didactic program as a case based presentation and at a corporate sponsored symposium at the Orthopedic Summit 2019: Evolving Techniques (OSET 2019) annual meeting in Las Vegas.
Read more Sensoria Announces Total End-to-End Knee Replacement Surgery at the CES 2020
About the size of a wristwatch and worn at the knee, the geko device is a wearable edema management therapy. Through an innovative mechanism of bioelectronic neuromuscular electrostimulation, the daily disposable device gently stimulates the common peroneal nerve activating the calf and foot muscle pumps, resulting in increased blood flow in the deep veins of the calf for the prevention and treatment of pre and post-operative edema and the prevention of venous thromboembolism (VTE) – in both surgical and medical patients at risk of VTE, says a press release.
Jason Snibbe, MD, a fellow from the Kerlan-Jobe institute, USC team surgeon, and an orthopedic surgeon practicing in Los Angeles, CA presented the clinical rationale and his use of the FDA cleared geko device to prevent the build-up of edema on the lower extremity orthopedic procedures he performs. He presented a real-world total knee replacement (TKR) patient case study to an audience of over 900 orthopedic surgeons and healthcare professionals. The case focused on the patient’s range of motion and mobility issues following total knee arthroplasty, where edema was determined as the culprit.
Post-operative edema occurs in over 90% of total hip and knee replacement patients, and is one of the main post-operative challenges where there is no dependable solution.
Evidence presented also demonstrated that swelling complications are experienced beyond 50 days, continuing in many patients for over 3 months, as well as RCT data demonstrating geko device prevention of post-operative edema build-up in total hip replacement patients.
Sky Medical is headquartered in the UK and backed by leading international investors in both healthcare and technology.
